Haloperidol–induced catalepsy is ameliorated by deep brain stimulation of the inferior colliculus

K. Engelhardt,Philine Marchetta,R. Schwarting,L. Melo-Thomas

DOI: https://doi.org/10.1038/s41598-018-19990-y

IF: 4.6

2018-02-02

Scientific Reports

Abstract:

What problem does this paper attempt to address?

Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology

K E Luker,J L Collier,E W Kolodziej,G R Marshall,W E Goldman

DOI: https://doi.org/10.1073/pnas.90.6.2365

1993-03-15

Abstract:Tracheal cytotoxin (TCT) is a disaccharide-tetrapeptide released by Bordetella pertussis, the causative agent of pertussis (whooping cough). We have previously determined the structure of TCT to be GlcNAc-1,6-anhydro-MurNAc-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala, where MurNAc = N-acetylmuramic acid and A2pm = diaminopimelic acid. Purified TCT reproduces the respiratory cytopathology observed during pertussis, including ciliostasis and extrusion of ciliated cells. We have tested structural analogs of TCT for their ability to reproduce native TCT toxicity in explanted hamster tracheal tissue and hamster trachea epithelial (HTE) cell cultures. Other investigators have evaluated many of these analogs, which are muramyl or desmuramyl peptides, for muramyl peptide activities such as immunopotentiation, induction of slow-wave sleep, and pyrogenicity. Four desmuramyl peptides were produced in our laboratory from B. pertussis peptidoglycan or by chemical synthesis, including unusual peptides containing alpha-aminopimelic acid in place of A2pm. Based on the relative ability of compounds to inhibit DNA synthesis in HTE cells, truncated analogs lacking A2pm entirely or lacking only the side-chain amine or carboxyl group of A2pm were less active than TCT by a factor of at least 1000. All active analogs included a native or near-native peptide moiety, independent of the presence, absence, or substitution of the sugar moiety. We conclude that the structural requirements for TCT toxicity differ considerably from those for most other muramyl peptide activities, in that the disaccharide moiety is irrelevant for toxicity and both the free amino and carboxyl groups of the A2pm side chain are required for activity.
Association of Pertussis Toxin with Severe Pertussis Disease

Karen Scanlon,Ciaran Skerry,Nicholas Carbonetti

DOI: https://doi.org/10.3390/toxins11070373

IF: 5.075

2019-06-27

Toxins

Abstract:Pertussis, caused by respiratory tract infection with the bacterial pathogen Bordetella pertussis, has long been considered to be a toxin-mediated disease. Bacteria adhere and multiply extracellularly in the airways and release several toxins, which have a variety of effects on the host, both local and systemic. Predominant among these toxins is pertussis toxin (PT), a multi-subunit protein toxin that inhibits signaling through a subset of G protein-coupled receptors in mammalian cells. PT activity has been linked with severe and lethal pertussis disease in young infants and a detoxified version of PT is a common component of all licensed acellular pertussis vaccines. The role of PT in typical pertussis disease in other individuals is less clear, but significant evidence supporting its contribution to pathogenesis has been accumulated from animal model studies. In this review we discuss the evidence indicating a role for PT in pertussis disease, focusing on its contribution to severe pertussis in infants, modulation of immune and inflammatory responses to infection, and the characteristic paroxysmal cough of pertussis.

toxicology,food science & technology
A Novel Adhesin of B. pertussis is Key to Colonisation of Epithelial Cells

Michael Gollan,Monica C Gestal,Katelyn M Parrish,Eric T Harvill,Andrew Preston,Iain MacArthur

DOI: https://doi.org/10.1101/2024.09.23.613229

2024-09-23

Abstract:Despite effective vaccines to protect against Whooping cough, or pertussis, the disease is resurgent in many countries. A switch from acellular to whole-cell vaccines has resulted in waning protective immunity, likely contributing to increases in infection prevalence, underlining the need to better understand B. pertussis virulence. As a respiratory pathogen, B. pertussis colonises the upper respiratory tract utilising an array of adhesins, four of which (FHA, pertactin, Fim2/3) are included in the acellular vaccine. In this study, we identified two Bvg regulated genes that are upregulated during virulence conditions and thus potentially involved in pathogenesis. bp1251 and bp1252 encode orphan toxin B subunits, with homology to AB toxin B subunits. Mutation of bp1251 and bp1252 reduced the in vitro adherence of B. pertussis to A549 and BEAS-2B alveolar and bronchial epithelial-like cells. In a murine model of infection, bp1251 and bp1252 mutant strains were recovered from the nasal cavity and lungs at lower levels than WT. In vitro no effect of mutation of bp1251 or bp1252 on cell invasion or toxicity was found suggesting that these proteins do not form part of a toxin. Given their homology to B subunits of AB toxins, and their role in colonisation, we propose that BP1251 and BP1252 are novel adhesins. Our data suggests that these proteins play a significant role in Bordetella infection and have the potential to further the understanding of B. pertussis pathogenesis.

Microbiology
Structural Basis for Antibody Neutralization of Pertussis Toxin

Jory A Goldsmith,Annalee W Nguyen,Rebecca E Wilen,Wassana Wijagkanalan,Jason S McLellan,Jennifer A Maynard

DOI: https://doi.org/10.1101/2024.09.23.614357

2024-09-23

Abstract:Pertussis toxin (PT) is a key protective antigen in vaccine- and natural immunity-mediated protection from Bordetella pertussis infection. Despite its importance, no PT-neutralizing epitopes have been characterized structurally. To define neutralizing epitopes and identify key structural elements to preserve during PT antigen design, we determined a 3.6 A cryo-electron microscopy structure of genetically detoxified PT (PTg) bound to hu11E6 and hu1B7, two potently neutralizing anti-PT antibodies with complementary mechanisms: disruption of toxin adhesion to cells and intracellular activities, respectively. Hu11E6 bound the paralogous S2 and S3 subunits of PTg via a conserved epitope, but surprisingly did not span the sialic acid binding site implicated in toxin adhesion. High-throughput glycan array analysis showed that hu11E6 specifically prevents PTg binding to sialylated N-glycans, while a T cell activation assay showed that hu11E6 blocks PTg mitogenic activities to define the neutralizing mechanism. Hu1B7 bound a quaternary epitope spanning the S1 and S5 subunits, although functional studies of hu1B7 variants suggested that S5 binding is not involved in its PT neutralization mechanism. These results are the first to structurally define neutralizing epitopes on PT, improving our molecular understanding of immune protection from B. pertussis and providing key information for the future development of PT immunogens.

Biochemistry
The mature c-terminal domain of filamentous hemagglutinin is sufficient to provide protection against Bordetella pertussisin the murine nasal cavity

M. Barbier,F. Damron,Kelly L. Weaver,Annalisa B. Huckaby,William T. Witt,G. Pyles,Margalida Mateu-Borrás

DOI: https://doi.org/10.4049/jimmunol.210.supp.253.12

2023-05-01

Abstract:Bordetella pertussis is the causative agent of whooping cough. The transition from whole cell (wP) to acellular pertussis vaccines (aPs) triggered an increase in pertussis incidence despite wide-spread vaccine coverage. aPs contain protein antigens purified from B. pertussis: pertactin, fimbriae, filamentous hemagglutinin (FHA), and pertussis toxin (PT). Antibodies are critical for protection against B. pertussis, and have been demonstrated to trigger opsonization, block bacterial adhesion, and neutralize disease symptoms. Following aP-vaccination, however, antibodies target a diminished number of functional B cell epitopes as the antigens are chemically denatured during aP manufacturing. The effects of denaturation on PT are well documented, but this has not been studied for other vaccine antigens, such as FHA. Additionally, FHA is a large antigen, and most of the protein does not play a role in bacterial adhesion. To direct antibody responses toward non-denatured, functionally relevant portions of FHA we aimed to test the Mature C-terminal Domain (MCD) of FHA as vaccine antigen. Protection provided by MCD was compared to several vaccine preparations, including aP and native FHA. We observed that aP and wP vaccines lead to the induction of antibodies that recognize FHA, MCD and B. pertussis. Using a CD-1 murine model of vaccination and challenge we demonstrated that MCD is immunogenic and sufficient to decrease bacterial burden in the murine airway, providing ~85% reduction in B. pertussis present in the nasal cavity. Overall, our data supports the use of MCD as a vaccine antigen for protection against B. pertussis. Ongoing studies focus on the selection of the adjuvants and route of administration to optimize vaccine efficacy. Mariette Barbier is funded by NIH grant 5R01AI141671-04. Fredrick Damron is funded by NIH grant 5R01AI137155-04. The Vaccine Development Center Research Challenge Grant (no. HEPC.dsr.18.6) from the Division of Science and Research, WV Higher Education Policy Commission also contributed support.

Biology,Medicine
Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions

Maria Bianchi,Rinu Sivarajan,Thorsten Walles,Stephan Hackenberg,Maria Steinke

DOI: https://doi.org/10.1177/1753425920979354

2020-12-14

Innate Immunity

Abstract:The human pathogen Bordetella pertussis targets the respiratory epithelium and causes whooping cough. Its virulence factor adenylate cyclase toxin (CyaA) plays an important role in the course of infection. Previous studies on the impact of CyaA on human epithelial cells have been carried out using cell lines derived from the airways or the intestinal tract. Here, we investigated the interaction of CyaA and its enzymatically inactive but fully pore-forming toxoid CyaA-AC – with primary human airway epithelial cells (hAEC) derived from different anatomical sites (nose and tracheo-bronchial region) in two-dimensional culture conditions. To assess possible differences between the response of primary hAEC and respiratory cell lines directly, we included HBEC3-KT in our studies. In comparative analyses, we studied the impact of both the toxin and the toxoid on cell viability, intracellular cAMP concentration and IL-6 secretion. We found that the selected hAEC, which lack CD11b, were differentially susceptible to both CyaA and CyaA-AC – . HBEC3-KT appeared not to be suitable for subsequent analyses. Since the nasal epithelium first gets in contact with airborne pathogens, we further studied the effect of CyaA and its toxoid on the innate immunity of three-dimensional tissue models of the human nasal mucosa. The present study reveals first insights in toxin–cell interaction using primary hAEC.

microbiology,biochemistry & molecular biology,immunology,medicine, research & experimental
Study on Purification and Biological Characteristics of Pertactin from Bordetella Pertussis

WANG Ling,XIAO Zhan-rong,YE Juan,HAN Jun-jie,SUN Xiang-yu

DOI: https://doi.org/10.3760/cma.j.issn.1673-4211.2012.01.001

2012-01-01

Abstract:Objective To establish a method for purifying pertactin from Bordetella pertussis,study its biological characteristics and confirm its role in acellular pertussis vaccine.Methods Bordetella pertussis CS strain was cultured in a fermenter,and purified pertactin was obtained by hot lixiviation,ammonium sulfate fractional precipitation and ion-exchange chromatography.Purity and biological characteristics of the purified pertactin were studied according to requirements of Pharmacopoeia of the People's Republic of China 2005 Volume Ⅲ.Results The purity of the purified pertactin was above 95％,relative molecular mass and isoelectric point of the purified pertactin were identical with those of standard pertactin.Protective potency of the purified pertactin was observed in mice and enhanced with increase of its concentrations.No specific and abnormal toxicities were detected.Conclusions The method for purifying pertactin from Bordetella pertussis is established,and purified pertactin has immunogenicity and protective potency.
Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells

Zachary M. Nash,Carol S. Inatsuka,Peggy A. Cotter,Richard M. Johnson

DOI: https://doi.org/10.1128/mbio.00632-24

IF: 6.4

2024-03-28

mBio

Abstract:ABSTRACT Bordetella species that cause respiratory infections in mammals include B. pertussis , which causes human whooping cough, and B. bronchiseptica , which infects nearly all mammals. Both bacterial species produce filamentous hemagglutinin (FhaB) and adenylate cyclase toxin (ACT), prominent surface-associated and secreted virulence factors that contribute to persistence in the lower respiratory tract by inhibiting clearance by phagocytic cells. FhaB and ACT proteins interact with themselves, each other, and host cells. Using immunoblot analyses, we showed that ACT binds to FhaB on the bacterial surface before it can be detected in culture supernatants. We determined that SphB1, a surface protease identified based on its requirement for FhaB cleavage, is also required for ACT cleavage, and we determined that the presence of ACT blocks SphB1-dependent and -independent cleavage of FhaB, but the presence of FhaB does not affect SphB1-dependent cleavage of ACT. The primary SphB1-dependent cleavage site on ACT is proximal to ACT’s active site, in a region that is critical for ACT activity. We also determined that FhaB-bound ACT on the bacterial surface can intoxicate host cells producing CR3, the receptor for ACT. In addition to increasing our understanding of FhaB, ACT, and FhaB-ACT interactions on the Bordetella surface, our data are consistent with a model in which FhaB functions as a novel toxin delivery system by binding to ACT and allowing its release upon binding of ACT to its receptor, CR3, on phagocytic cells. IMPORTANCE Bacteria need to control the variety, abundance, and conformation of proteins on their surface to survive. Members of the Gram-negative bacterial genus Bordetella include B. pertussis , which causes whooping cough in humans, and B. bronchiseptica , which causes respiratory infections in a broad range of mammals. These species produce two prominent virulence factors, the two-partner secretion (TPS) effector FhaB and adenylate cyclase toxin (ACT), that interact with themselves, each other, and host cells. Here, we determined that ACT binds FhaB on the bacterial surface before being detected in culture supernatants and that ACT bound to FhaB can be delivered to eukaryotic cells. Our data are consistent with a model in which FhaB delivers ACT specifically to phagocytic cells. This is the first report of a TPS system facilitating the delivery of a separate polypeptide toxin to target cells and expands our understanding of how TPS systems contribute to bacterial pathogenesis.

microbiology
Experimental analysis of hydrodynamic journal bearing under different biolubricants

S. Baskar,G. Sriram

2012-03-30

Abstract:The main objective of this study is to analyze the pressure distribution on hydrodynamic journal bearing under different lubricants for various loading conditions and various operating parameters. The space between the shaft and the bearing is filled with different lubricants. Journal bearing test rig (JBTR) is used to test the 40 mm diameter and 40 mm long bearing. Test bearing is located between two antifriction bearings and loaded mechanically. At first the bearing is tested in JBTR under SAE20W40 of various load conditions such as 300N and 450N and speed ranges such as 1500 rpm and 1750 rpm and the pressure distribution results were observed and recorded. The vegetable oils such as rapeseed oil and soya bean oil were tested under the same operating conditions in the JBTR and the results are compared with the SAE20W40.
Toll-erating self DNA

S. Bauer

DOI: https://doi.org/10.1038/ni0106-13

IF: 30.5

Nature Immunology

Abstract:
Lipid binding by N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA

Ivana Malcova,Ladislav Bumba,Filip Uljanic,Darya Kuzmenko,Jana Nedomova,Jana Kamanova

DOI: https://doi.org/10.1101/2020.11.17.386359

2020-11-17

Abstract:Abstract The classical Bordetella species, B. pertussis and B. bronchiseptica , employ a type III secretion system (T3SS) to inject a 69-kDa BteA effector into the host cells. Upon injection, BteA localizes to the cytosolic leaflet of lipid rafts via its N-terminal lipid raft targeting (LRT) domain and induces cell death. The plasma membrane targeting and cytotoxicity mechanisms of BteA are poorly understood. Using protein-lipid overlay assay and surface plasmon resonance, we showed here that the recombinant LRT domain, which adopts a four-helix bundle topology of membrane localization domains, specifically binds negatively charged membrane phospholipids. The binding affinity for phosphatidylinositol 4,5-bisphosphate (PIP2)-containing liposomes with Kd ~450 nM was higher than for those enriched in phosphatidylserine (Kd ~1.2 μM) while both phospholipids were required for plasma membrane targeting in yeast cells. The membrane association of LRT further depended on its electrostatic and hydrophobic interactions and involved a loop L1-located leucine residue. Importantly, charge-reversal substitutions within the L1 region disrupted plasma membrane localization of BteA effector without hampering its cytotoxic activity during B. bronchiseptica infection of HeLa cells. The LRT-mediated targeting of BteA to the cytosolic leaflet of the plasma membrane of host cells is, hence, dispensable for the effector cytotoxicity. Author summary The respiratory pathogens of humans and other animals, Bordetella pertussis and Bordetella bronchiseptica , produce a type III secretion system effector protein BteA. This effector consists of two functional domains, an N-terminal lipid raft targeting (LRT) domain, and a cytotoxic C-terminal domain, which induces non-apoptotic and caspase-1-independent host cell death. We found here that the LRT domain of BteA associates with plasma membrane by binding to negatively charged phospholipids. We further discovered that the mechanism of membrane association by LRT is reminiscent of the one used by three other diverse families of toxins: clostridial glucosyltransferase toxins, multifunctional-autoprocessing RTX toxins (MARTX), and Pasteurella multocida-like toxins. Intriguingly, we also report that plasma membrane targeting by the LRT domain does not contribute to cytotoxic activity of BteA during B. bronchiseptica infection. Overall, our work elucidated the mechanism of plasma membrane association by LRT, and further provided the basis for future research on cellular activities of BteA and the mechanism of BteA-induced cell death.
Revisiting bacterial cytolethal distending toxin structure and function

Henry Chen,Claire J Ang,Molly K Crowder,William M Brieher,Steven R Blanke

DOI: https://doi.org/10.3389/fcimb.2023.1289359

2023-11-14

Abstract:Cytolethal distending toxins (CDTs) are intracellular-acting bacterial genotoxins generated by a diverse group of mucocutaneous human pathogens. CDTs must successfully bind to the plasma membrane of host cells in order to exert their modulatory effects. Maximal toxin activity requires all three toxin subunits, CdtA, CdtB, and CdtC, which, based primarily on high-resolution structural data, are believed to preassemble into a tripartite complex necessary for toxin activity. However, biologically active toxin has not been experimentally demonstrated to require assembly of the three subunits into a heterotrimer. Here, we experimentally compared concentration-dependent subunit interactions and toxin cellular activity of the Campylobacter jejuni CDT (Cj-CDT). Co-immunoprecipitation and dialysis retention experiments provided evidence for the presence of heterotrimeric toxin complexes, but only at concentrations of Cj-CdtA, Cj-CdtB, and Cj-CdtC several logs higher than required for Cj-CDT-mediated arrest of the host cell cycle at the G2/M interface, which is triggered by the endonuclease activity associated with the catalytic Cj-CdtB subunit. Microscale thermophoresis confirmed that Cj-CDT subunit interactions occur with low affinity. Collectively, our data suggest that at the lowest concentrations of toxin sufficient for arrest of cell cycle progression, mixtures of Cj-CdtA, Cj-CdtB, and Cj-CdtC consist primarily of non-interacting, subunit monomers. The lack of congruence between toxin tripartite structure and cellular activity suggests that the widely accepted model that CDTs principally intoxicate host cells as preassembled heterotrimeric structures should be revisited.
Outer membrane proteins of Bordetella pertussis function as a modulator on promoting degranulation of mastocyte in vitro

严杰,毛亚飞,邵浙新

DOI: https://doi.org/10.3760/j:issn:0254-5101.2004.08.006

2004-01-01

Abstract:Objective To understand the correlation between the biological activity of out membrane proteins(OMPs) of B. pertussis strain phase I and IgE-mediated asthma. Methods OMPs and its components from B. pertussis phase I strain 58001 were prepared by detergent treatment, DEAE-52 and Sephadex G-150 chromatography. The molecular mass of the OMP components were measured by SDS-PAGE. By using limulus lysate assay, the endotoxin activity of the preparations was detected. An ELISA was established to determine the effects of whole dead B. pertussis on inducing total IgE and ovalbumin (OVA)-specific IgE. Mastocyte degranulation test was performed to observe the activities of the OMPs and its components on promoting degranulation in guinea pig mastocyte and the histamine in the supernatant of the cultures was detected by ELISA. Histamine sensitive test was used to demonstrate the effects of the OMPs and its components on increasing histamine lethal sensitivity in mice. Results Four components with molecular mass of 30 000, 32 000, 38 000 and 69 000 from the B. pertussis OMPs were obtained by chromatography. These preparations did not show any activity of coagulating limulus lysate at the concentrations of 1-100μg/ml. When the guinea pigs were co-immunized with OVA and whole dead B. pertussis, the total IgE and OVA-specific IgE in the animals' sera were significantly increased than those immunized with OVA alone (t = 2.75-6.59; P < 0.05-0.01). The OMPs and its two components with molecular mass of 30 000 and 32 000 showed remarkably positive inducement on degranulation of guinea pig mastocytes (t = 4.914-9.137, P < 0.01) but the other two components did not. The histamine levels in the supernatants treated with the OMPs and its molecular mass of 30 000 and 32 000 components were significantly higher than those of the negative controls (t = 5.672-9.304, P < 0. 01) but molecular mass of 38 000 and 69 000 components were not. Conclusion We proved the strong IgE adjuvant activity of B. pertussis and the effects of some components from the bacterial OMPs on promoting degranulation of mastocyte and release of histamine in vitro, and increasing histamine lethality in vivo which indicated a close correlation between the infection or vaccination of B. pertussis and IgE-mediated asthma.
Four single-basepair mutations in the ptx promoter of Bordetella bronchiseptica are sufficient to activate the expression of pertussis toxin

Qing Chen,Mary C. Gray,Erik Hewlett,Scott Stibitz

DOI: https://doi.org/10.1038/s41598-021-88852-x

IF: 4.6

2021-04-30

Scientific Reports

Abstract:Abstract Secretion of pertussis toxin (PT) is the preeminent virulence trait of the human pathogen Bordetella pertussis , causing whooping cough. Bordetella bronchiseptica , although it harbors an intact 12-kb ptx–ptl operon, does not express PT due to an inactive ptx promoter (P ptx ), which contains 18 SNPs (single nucleotide polymorphisms) relative to B. pertussis P ptx . A systematic analysis of these SNPs was undertaken to define the degree of mutational divergence necessary to activate B. bronchiseptica P ptx . A single change (C −13 T), which created a better − 10 element, was capable of activating B. bronchiseptica P ptx sufficiently to allow secretion of low but measureable levels of active PT. Three additional changes in the BvgA-binding region, only in the context of C −13 T mutant, raised the expression of PT to B. pertussis levels. These results illuminate a logical evolutionary pathway for acquisition of this key virulence trait in the evolution of B. pertussis from a B. bronchiseptica -like common ancestor.

multidisciplinary sciences
The Chaperonin TRiC/CCT Inhibitor HSF1A Protects Cells from Intoxication with Pertussis Toxin

Jinfang Jia,Manuel Zoeschg,Holger Barth,Arto T. Pulliainen,Katharina Ernst

DOI: https://doi.org/10.3390/toxins16010036

IF: 5.075

2024-01-11

Toxins

Abstract:Pertussis toxin (PT) is a bacterial AB5-toxin produced by Bordetella pertussis and a major molecular determinant of pertussis, also known as whooping cough, a highly contagious respiratory disease. In this study, we investigate the protective effects of the chaperonin TRiC/CCT inhibitor, HSF1A, against PT-induced cell intoxication. TRiC/CCT is a chaperonin complex that facilitates the correct folding of proteins, preventing misfolding and aggregation, and maintaining cellular protein homeostasis. Previous research has demonstrated the significance of TRiC/CCT in the functionality of the Clostridioides difficile TcdB AB-toxin. Our findings reveal that HSF1A effectively reduces the levels of ADP-ribosylated Gαi, the specific substrate of PT, in PT-treated cells, without interfering with enzyme activity in vitro or the cellular binding of PT. Additionally, our study uncovers a novel interaction between PTS1 and the chaperonin complex subunit CCT5, which correlates with reduced PTS1 signaling in cells upon HSF1A treatment. Importantly, HSF1A mitigates the adverse effects of PT on cAMP signaling in cellular systems. These results provide valuable insights into the mechanisms of PT uptake and suggest a promising starting point for the development of innovative therapeutic strategies to counteract pertussis toxin-mediated pathogenicity.

toxicology,food science & technology
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

Julian Parkhill,Mohammed Sebaihia,Andrew Preston,Lee D Murphy,Nicholas Thomson,David E Harris,Matthew T G Holden,Carol M Churcher,Stephen D Bentley,Karen L Mungall,Ana M Cerdeño-Tárraga,Louise Temple,Keith James,Barbara Harris,Michael A Quail,Mark Achtman,Rebecca Atkin,Steven Baker,David Basham,Nathalie Bason,Inna Cherevach,Tracey Chillingworth,Matthew Collins,Anne Cronin,Paul Davis,Jonathan Doggett,Theresa Feltwell,Arlette Goble,Nancy Hamlin,Heidi Hauser,Simon Holroyd,Kay Jagels,Sampsa Leather,Sharon Moule,Halina Norberczak,Susan O'Neil,Doug Ormond,Claire Price,Ester Rabbinowitsch,Simon Rutter,Mandy Sanders,David Saunders,Katherine Seeger,Sarah Sharp,Mark Simmonds,Jason Skelton,Robert Squares,Steven Squares,Kim Stevens,Louise Unwin,Sally Whitehead,Bart G Barrell,Duncan J Maskell

DOI: https://doi.org/10.1038/ng1227

IF: 30.8

2003-08-10

Nature Genetics

Abstract:Bordetella bronchiseptica encodes and expresses a flagellar apparatus. In contrast, Bordetella pertussis, the causative agent of whooping cough, has historically been described as a nonmotile and nonflagellated organism. The previous statements that B. pertussis was a nonmotile organism were consistent with a stop codon located in the flagellar biosynthesis gene, flhA, discovered when the B. pertussis Tohama I genome was sequenced and analyzed by Parkhill et al. in 2003 (J. Parkhill, M. Sebaihia, A. Preston, L. D. Murphy, et al., Nat Genet, 35:32–40, 2003, <a href="https://doi.org/10.1038/ng1227">https://doi.org/10.1038/ng1227</a>). The stop codon has subsequently been found in all annotated genomes. Parkhill et al. also showed, however, that B. pertussis contains all genetic material required for flagellar synthesis and function. We and others have determined by various transcriptomic analyses that these flagellar genes are differentially regulated under a variety of B. pertussis growth conditions. In light of these data, we tested for B. pertussis motility and found that both laboratory-adapted strains and clinical isolates can be motile. Upon isolation of motile B. pertussis, we discovered flagellum-like structures on the surface of the bacteria. B. pertussis motility appears to occur primarily in the Bvg(−) phase, consistent with regulation present in B. bronchiseptica. Motility can also be induced by the presence of fetal bovine serum. These observations demonstrate that B. pertussis can express flagellum-like structures, and although it remains to be determined if B. pertussis expresses flagella during infection or if motility and/or flagella play roles during the cycle of infection and transmission, it is clear that these data warrant further investigation.IMPORTANCE This report provides evidence for motility and expression of flagella by B. pertussis, a bacterium that has been reported as nonmotile since it was first isolated and studied. As with B. bronchiseptica, B. pertussis cells can express and assemble a flagellum-like structure on their surface, which in other organisms has been implicated in several important processes that occur in vivo. The discovery that B. pertussis is motile raises many questions, including those regarding the mechanisms of regulation for flagellar gene and protein expression and, importantly, the role of flagella during infection. This novel observation provides a foundation for further study of Bordetella flagella and motility in the contexts of infection and transmission.

genetics & heredity
Glycan-dependent cell adhesion mechanism of Tc toxins

Daniel Roderer,Felix Bröcker,Oleg Sitsel,Paulina Kaplonek,Franziska Leidreiter,Peter H. Seeberger,Stefan Raunser

DOI: https://doi.org/10.1038/s41467-020-16536-7

IF: 16.6

2020-06-01

Nature Communications

Abstract:Abstract Toxin complex (Tc) toxins are virulence factors of pathogenic bacteria. Tcs are composed of three subunits: TcA, TcB and TcC. TcA facilitates receptor–toxin interaction and membrane permeation, TcB and TcC form a toxin-encapsulating cocoon. While the mechanisms of holotoxin assembly and pore formation have been described, little is known about receptor binding of TcAs. Here, we identify heparins/heparan sulfates and Lewis antigens as receptors for different TcAs from insect and human pathogens. Glycan array screening reveals that all tested TcAs bind negatively charged heparins. Cryo-EM structures of Morganella morganii TcdA4 and Xenorhabdus nematophila XptA1 reveal that heparins/heparan sulfates unexpectedly bind to different regions of the shell domain, including receptor-binding domains. In addition, Photorhabdus luminescens TcdA1 binds to Lewis antigens with micromolar affinity. Here, the glycan interacts with the receptor-binding domain D of the toxin. Our results suggest a glycan dependent association mechanism of Tc toxins on the host cell surface.

multidisciplinary sciences
Designer probiotics for the prevention and treatment of human diseases.

Koon Jiew Chua,Wee Chiew Kwok,Nikhil Aggarwal,Tao Sun,M. Chang

DOI: https://doi.org/10.1016/j.cbpa.2017.04.011

IF: 8.972

2017-10-01

Current Opinion in Chemical Biology

Abstract:
Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine

J A Bogdan,J Nazario-Larrieu,J Sarwar,P Alexander,M S Blake

DOI: https://doi.org/10.1128/IAI.69.11.6823-6830.2001

Abstract:Pertussis toxin (Ptx) expression and secretion in Bordetella pertussis are regulated by a two-component signal transduction system encoded by the bvg regulatory locus. However, it is not known whether the metabolic pathways and growth state of the bacterium influence synthesis and secretion of Ptx and other virulence factors. We have observed a reduction in the concentration of Ptx per optical density unit midway in fermentation. Studies were conducted to identify possible factors causing this reduction and to develop culture conditions that optimize Ptx expression. Medium reconstitution experiments demonstrated that spent medium and a fraction of this medium containing components with a molecular weight of <3,000 inhibited the production of Ptx. A complete flux analysis of the intermediate metabolism of B. pertussis revealed that the sulfur-containing amino acids methionine and cysteine and the organic acid pyruvate accumulated in the media. In fermentation, a large amount of internal sulfate (SO4(2-)) was observed in early stage growth, followed by a rapid decrease as the cells entered into logarithmic growth. This loss was later followed by the accumulation of large quantities of SO4(2-) into the media in late-stage fermentation. Release of SO4(2-) into the media by the cells signaled the decoupling of cell growth and Ptx production. Under conditions that limited cysteine, a fivefold increase in Ptx production was observed. Addition of barium chloride (BaCl2) to the culture further increased Ptx yield. Our results suggest that B. pertussis is capable of autoregulating the activity of the bvg regulon through its metabolism of cysteine. Reduction of the amount of cysteine in the media results in prolonged vir expression due to the absence of the negative inhibitor SO4(2-). Therefore, the combined presence and metabolism of cysteine may be an important mechanism in the pathogenesis of B. pertussis.
Bacterial intracellularly active toxins: Membrane localisation of the active domain

Carolina Varela‐Chavez,Arnaud Blondel,Michel R. Popoff

DOI: https://doi.org/10.1111/cmi.13213

2020-05-28

Cellular Microbiology

Abstract:Numerous bacterial toxins exert their activity by inactivating or modulating a specific intracellular host target. For this purpose, these toxins have developed efficient strategies to overcome the different host cell defenses including specific binding to cell surface, internalization, passage through the endosome or plasma membrane, exploiting intracellular trafficking and addressing to intracellular targets. Several intracellularly active toxins deliver an active domain into the cytosol that interacts with a target localized to the inner face of the plasma membrane. Thus, the large clostridial glucosylating toxins (LCGTs) target Rho/Ras‐GTPases, certain virulence factors of Gram negative bacteria, Rho‐GTPases, while Pasteurella multocida toxin (PMT) targets trimeric G‐proteins. Others such as botulinum neurotoxins and tetanus neurotoxin have their substrate on synaptic vesicle membrane. LCGTs, PMT, and certain virulence factors from Vibrio sp. show a particular structure constituted of a 4 α‐helices bundle (4HBM) protruding from the catalytic site that specifically binds to the membrane phospholipids and then trap the catalytic domain at the proximity of the membrane anchored substrate. Structural and functional analysis indicate that the 4HBM tip of the Clostridium sordellii lethal toxin (TcsL) from the LCGT family contain two loops forming a cavity that mediates the binding to phospholipids and more specifically to phosphatidylserine.This article is protected by copyright. All rights reserved.

cell biology,microbiology

Haloperidol–induced catalepsy is ameliorated by deep brain stimulation of the inferior colliculus

Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology

Association of Pertussis Toxin with Severe Pertussis Disease

A Novel Adhesin of B. pertussis is Key to Colonisation of Epithelial Cells

Structural Basis for Antibody Neutralization of Pertussis Toxin

The mature c-terminal domain of filamentous hemagglutinin is sufficient to provide protection against Bordetella pertussisin the murine nasal cavity

Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions

Study on Purification and Biological Characteristics of Pertactin from Bordetella Pertussis

Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells

Experimental analysis of hydrodynamic journal bearing under different biolubricants

Toll-erating self DNA

Lipid binding by N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA

Revisiting bacterial cytolethal distending toxin structure and function

Outer membrane proteins of Bordetella pertussis function as a modulator on promoting degranulation of mastocyte in vitro

Four single-basepair mutations in the ptx promoter of Bordetella bronchiseptica are sufficient to activate the expression of pertussis toxin

The Chaperonin TRiC/CCT Inhibitor HSF1A Protects Cells from Intoxication with Pertussis Toxin

Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica

Glycan-dependent cell adhesion mechanism of Tc toxins

Designer probiotics for the prevention and treatment of human diseases.

Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine

Bacterial intracellularly active toxins: Membrane localisation of the active domain